Literature DB >> 20461636

Stem cell tourism and doctors' duties to minors--a view from Canada.

Amy Zarzeczny1, Timothy Caulfield.   

Abstract

While the clinical promise of much stem cell research remains largely theoretical, patients are nonetheless pursuing unproven stem cell therapies in jurisdictions around the world--a phenomenon referred to as "stem cell tourism." These treatments are generally advertised on a direct-to-consumer basis via the Internet. Research shows portrayals of stem cell medicine on such websites are overly optimistic and the claims made are unsubstantiated by published evidence. However, anecdotal evidence suggests that parents are pursuing these "treatments" for their children, despite potential physical and financial risk. Physicians are in a unique position as they can be expected to be involved in, or privy to, such decisions. In this paper, we consider what duties physicians may have toward minor patients whose parents/guardians wish to engage in stem cell tourism on their behalf. We use the Canadian perspective to address the broadly relevant issues raised by this trend.

Entities:  

Mesh:

Year:  2010        PMID: 20461636     DOI: 10.1080/15265161003702865

Source DB:  PubMed          Journal:  Am J Bioeth        ISSN: 1526-5161            Impact factor:   11.229


  17 in total

1.  Hype and public trust in science.

Authors:  Zubin Master; David B Resnik
Journal:  Sci Eng Ethics       Date:  2011-11-02       Impact factor: 3.525

2.  Stem cell tourism and Canadian family physicians.

Authors:  Timothy Caulfield; Amy Zarzeczny
Journal:  Can Fam Physician       Date:  2012-04       Impact factor: 3.275

3.  Direct-to-consumer stem cell marketing and regulatory responses.

Authors:  Douglas Sipp
Journal:  Stem Cells Transl Med       Date:  2013-08-09       Impact factor: 6.940

4.  Stem-cell tourism and scientific responsibility. Stem-cell researchers are in a unique position to curb the problem of stem-cell tourism.

Authors:  Zubin Master; David B Resnik
Journal:  EMBO Rep       Date:  2011-09-30       Impact factor: 8.807

5.  Navigating physicians' ethical and legal duties to patients seeking unproven interventions abroad.

Authors:  Jeremy Snyder; Krystyna Adams; Y Y Chen; Daniel Birch; Timothy Caulfield; I Glenn Cohen; Valorie A Crooks; Judy Illes; Amy Zarzeczny
Journal:  Can Fam Physician       Date:  2015-07       Impact factor: 3.275

6.  When ethics constrains clinical research: trial design of control arms in "greater than minimal risk" pediatric trials.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2011-05-19       Impact factor: 5.695

7.  Fantasies about stem cell therapy in chronic ischemic stroke patients.

Authors:  Young Seo Kim; Dan-Il Chung; Hojin Choi; Wonki Baek; Hyun Young Kim; Sung Hyuk Heo; Dae-Il Chang; Hae Ri Na; Seung Hyun Kim; Seong-Ho Koh
Journal:  Stem Cells Dev       Date:  2012-08-06       Impact factor: 3.272

8.  In the Know and in the News: How Science and the Media Communicate About Stem Cells, Autism and Cerebral Palsy.

Authors:  Kimberly Sharpe; Nina Di Pietro; Judy Illes
Journal:  Stem Cell Rev Rep       Date:  2016-02       Impact factor: 5.739

9.  A Dichotomy of Information-Seeking and Information-Trusting: Stem Cell Interventions and Children with Neurodevelopmental Disorders.

Authors:  Kimberly Sharpe; Nina Di Pietro; Karen J Jacob; Judy Illes
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

Review 10.  Managing the potential and pitfalls during clinical translation of emerging stem cell therapies.

Authors:  Heather Main; Megan Munsie; Michael D O'Connor
Journal:  Clin Transl Med       Date:  2014-05-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.